We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,952

OIG Revokes Patient Assistance Program Advisory Opinion Protection
  • Cooley LLP
  • USA
  • December 11 2017

The Office of Inspector General (OIG) rescinded Advisory Opinion 06-04 (Opinion 06-04) on November 28, 2017, retroactive to its original issuance date


Athens Court confirms validity of Janssen’s Patent and grants high amount of compensations
  • Dr Helen G Papaconstantinou and Partners Law Firm
  • Greece
  • December 6 2017

In Janssen Pharmaceutica N.V. against Greek pharmaceutical companies (Decision no. 21112017, June 22, 2017) the Athens Court of First Instance


CMS’ Cuts to the 340B Drug Payment Program Cause Hospital Uproar
  • Frost Brown Todd LLC
  • USA
  • December 1 2017

The 340B program requires drug or pharmaceutical manufacturers to provide outpatient drugs to eligible health care organizations at significantly


Court of Appeal dismisses appeal by parallel importer who infringed pharmaceutical trade mark
  • Addleshaw Goddard LLP
  • United Kingdom
  • November 30 2017

The respondent, Flynn Pharma Limited (Flynn), was a pharmaceutical company using the name FLYNN, a UK and EU registered trade mark, in respect of its


Pharma Sector Inquiry ‘Encore’
  • Bristows LLP
  • United Kingdom, France
  • November 29 2017

In November 2017, the French competition authority, the Autorité de la concurrence, announced a new enquiry into the pharma sector. The issues set to


The French Competition Authority wants to lower prices of pharmaceuticals
  • Hogan Lovells
  • France
  • November 24 2017

On November 21, 2017, the French Competition Authority ("FCA") announced the launch of a new sector inquiry relating to the functioning of competition


Johnson & Johnson ordered to pay $417m in “talc litigation”
  • RPC
  • USA
  • November 24 2017

Johnson & Johnson has been ordered to pay $417m in damages after a jury in California found in favour of the claimant, who alleged that she had


French Pharma - French Competition Authority launches new sector enquiry
  • Bristows LLP
  • United Kingdom, France
  • November 23 2017

The CMA has opened an unprecedented number of new investigations in the pharmaceutical sector in the past month, with 4 new investigations during


Life Sciences: Compliance and enforcement in Greece
  • KYRIAKIDES GEORGOPOULOS Law Firm
  • Global, Greece
  • November 22 2017

A structured guide to compliance and dishonest practices in Greece


CMS Releases Major MAPart D Proposed Rule
  • Hogan Lovells
  • USA
  • November 22 2017

On November 16, 2017, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule to revise regulations, clarify program requirements